885270-73-5

Basic information

• Product Name: (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER
• Synonyms: (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER;tert-Butyl (3-aMino-4-chlorophenyl)carbaMate
• CAS NO: 885270-73-5
• Molecular Formula: C₁₁H₁₅ClN₂O₂
• Molecular Weight: 242.7
• Mol File: 885270-73-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER(885270-73-5)
• EPA Substance Registry System: (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER(885270-73-5)

Safety Data

• Statements: 43
• Safety Statements: 36/37
• Hazardous Substances Data: 885270-73-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a reagent in organic synthesis for its ability to participate in various chemical reactions, facilitating the formation of new compounds with desired properties.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a research compound to explore its potential applications in drug development. Its unique structure allows scientists to investigate its interactions with biological targets and evaluate its efficacy in treating specific conditions.
Used in Laboratory Settings:
Due to its stability and ease of handling, (3-AMINO-4-CHLORO-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER is used in laboratory settings for educational purposes and as a component in various experimental procedures. Its properties make it suitable for teaching and learning about chemical reactions and synthesis processes.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 6400-14-2 2-chloro-1,3-phenylenediamine 
• 606-21-3 1-chloro-2,6-dinitrobenzene 
• 635-22-3 4-Chloro-3-nitroaniline 

Downstream Products

• 916051-07-5 1,1-dimethylethyl {4-chloro-3-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)amino]phenyl}carbamate 
• 916050-65-2 2-[(5-amino-2-chlorophenyl)amino]-1,3-thiazol-4(5H)-one 
• 1172621-30-5 tert-butyl 4-chloro-3-(3-phenylureido)phenylcarbamate 
• 1172621-27-0 tert-butyl 4-chloro-3-(4-chlorobutanamido)phenylcarbamate 
• 1172621-20-3 tert-butyl 4-chloro-3-(isopropylamino)phenylcarbamate 
• 936638-03-8 N-{4-chloro-3-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)amino]phenyl}-2-methylpropanamide 
• 916051-89-3 2-chloro-N-{4-chloro-3-[(4-oxo-4,5-dihydro-1,3-thiazol-2-yl)amino]phenyl}acetamide 
• 916051-23-5 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)propanamide 
• 916052-73-8 4-chloro-N-(2-methylpropyl)-3-{[(5Z)-4-oxo-5-(6-quinoxalinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}benzamide 
• 916051-41-7 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-2-cyclopropylacetamide 
• 916051-25-7 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-2-(2-thienyl)acetamide 
• 916051-72-4 N-(4-chloro-3-{[(5Z)-4-oxo-5-(6-quinolinylmethylidene)-4,5-dihydro-1,3-thiazol-2-yl]amino}phenyl)-1-phenylmethanesulfonamide 

Relevant articles and documents

Design, Synthesis, and Characterization of a Fluorescence Polarization Pan-BET Bromodomain Probe

Several chemical probes have been developed for use in fluorescence polarization screening assays to aid in drug discovery for the bromodomain and extra-terminal domain (BET) proteins. However, few of those have been characterized in the literature. We ha

Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors

BRD4 and other members of the bromodomain and extraterminal (BET) family of proteins are promising epigenetic targets for the development of novel therapeutics. Among the reported BRD4 inhibitors are dihydropteridinones and benzopyrimidodiazepinones origi

BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Disclosed herein are compounds that are inhibitors of BDR4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BDR4 are also disclosed. In certain aspects, disclosed are compounds of Formula I through IV.

POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS

Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.

PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH

Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure:Formula (I). Wherein Q and R1-R3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.

NOVEL CHEMICAL COMPOUNDS

This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with hYAK3 activity.

NOVEL CHEMICAL COMPOUNDS

This invention relates to newly identified compounds for inhibiting hYAK3 proteins and methods for treating diseases associated with hYAK3 activity.